Inovio Pharmaceuticals (INO) Change in Account Payables (2016 - 2022)
Inovio Pharmaceuticals (INO) has disclosed Change in Account Payables for 13 consecutive years, with $859354.0 as the latest value for Q1 2022.
- Quarterly Change in Account Payables rose 585.88% to $859354.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $639125.0 through Mar 2022, down 12.11% year-over-year, with the annual reading at -$94937.0 for FY2021, 169.99% down from the prior year.
- Change in Account Payables hit $859354.0 in Q1 2022 for Inovio Pharmaceuticals, up from $56387.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.0 million in Q2 2021 to a low of -$1.3 million in Q3 2021.
- Historically, Change in Account Payables has averaged $41344.3 across 5 years, with a median of $125292.0 in 2021.
- Biggest five-year swings in Change in Account Payables: tumbled 553.11% in 2021 and later skyrocketed 585.88% in 2022.
- Year by year, Change in Account Payables stood at $286872.0 in 2018, then dropped by 6.88% to $267133.0 in 2019, then plummeted by 156.89% to -$151959.0 in 2020, then skyrocketed by 137.11% to $56387.0 in 2021, then surged by 1424.03% to $859354.0 in 2022.
- Business Quant data shows Change in Account Payables for INO at $859354.0 in Q1 2022, $56387.0 in Q4 2021, and -$1.3 million in Q3 2021.